$35.0M
The Series D round was led by Segulah Medical Acceleration, Angelus Venture Fund I, Alan Howard, and Pioneer Healthcare Partners to support commercial expansion.
"We believe that Signifier Medical Technologies has created the most disruptive, non-invasive treatment for OSA that the market has seen in the past 20 years."